Cormorant Asset Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Cormorant Asset Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell
2017 Q1	$10.1M	Buy
2016 Q4	$7.49M	Hold
2016 Q3	$6.27M	Hold
2016 Q2	$3.29M	Buy
2016 Q1	$4.49M	Buy
2015 Q4	$3.59M	Hold
2015 Q3	$5.1M	Buy